Boone S D, Decaluwé A-S, Van Melkebeke M, Saevels J, Mehuys E, Boussery K
Unité Soins Pharmaceutiques, Faculté des Sciences Pharmaceutiques, Université de Gand.
Centre de Développement Scientifique des Pharmaciens, Association Pharmaceutique Belge.
J Pharm Belg. 2013 Dec(4):6-13.
Counseling of patients filling a first prescription is an essentiaL aspect of pharmaceutical care. The use of a protocol summarizing all relevant counseling aspects can be a useful tool to standardize pharmaceutical care and to promote impLementation.
(1) To develop a protocol for counseling of patients starting with oral hypoglycaemic agents (OHA), and (2) to investigate current provision of counseling for these patients in Belgian community pharmacies.
Based on literature, a consensus meeting with community pharmacists and consultation with physicians, we developed a protocol for counseling patients starting OHA. Additionally, an observational study of current provision of counseling for patients starting OHA was performed in 90 community pharmacies.
All pharmacists reported to provide the most important item of our protocol, i.e. dose and timing of OHA intake. All other protocol items were provided by a smaller proportion of pharmacists: indication (by 64.4% of pharmacists), mechanism of action (30.0%), what to do if a dose is missed (3.3%), side effects (34.4%), hypoglycaemia (24.4%) and Lifestyle advice (68.9%). About 45% of pharmacists reported to give written drug information to patients starting OHA. Reduction of the administrative workload was most frequently mentioned as measure to spend more time on patient counseling. The majority of pharmacists considered our protocol as feasible and appLicabLe in daily pharmacy practice.
This study found that current counseLing practices for patients starting OHA can be improved. Our protocol could be a useful and feasible tool to facilitate implementation of first prescription counseling.
为首次开具处方的患者提供咨询是药学服务的一个重要方面。使用一份总结所有相关咨询要点的方案可以成为规范药学服务并促进其实施的有用工具。
(1)制定一份针对开始使用口服降糖药(OHA)患者的咨询方案,(2)调查比利时社区药房对这些患者目前的咨询服务情况。
基于文献、与社区药剂师召开的共识会议以及与医生的磋商,我们制定了一份针对开始使用OHA患者的咨询方案。此外,在90家社区药房对开始使用OHA患者目前的咨询服务情况进行了一项观察性研究。
所有药剂师均报告提供了我们方案中最重要的一项内容,即OHA的服用剂量和时间。其他方案内容由较少比例的药剂师提供:适应证(64.4%的药剂师)、作用机制(30.0%)、漏服一剂时的处理方法(3.3%)、副作用(34.4%)、低血糖(24.4%)以及生活方式建议(68.9%)。约45%的药剂师报告称会为开始使用OHA的患者提供书面药品信息。减少行政工作量是最常被提及的用于有更多时间进行患者咨询的措施。大多数药剂师认为我们的方案在日常药房实践中可行且适用。
本研究发现,目前针对开始使用OHA患者的咨询实践有待改进。我们的方案可能是促进首次处方咨询实施的一个有用且可行的工具。